Showing results (1-10 of 191) with videos related to
Sort By:
Pageof 20
Current Opinion in Immunology|February 13, 2007
Antibodies, Fc receptors and cancerFalk Nimmerjahn, Jeffrey V RavetchProceedings of the National Academy of Sciences of the United States of America|November 13, 2013
Antitumor activities of agonistic anti-TNFR antibodies require differential FcγRIIB coengagement in vivoFubin Li, Jeffrey V RavetchAdvances in Immunology|November 6, 2007
Fc-receptors as regulators of immunityFalk Nimmerjahn, Jeffrey V RavetchImmunological Reviews|October 27, 2015
Fcγ receptor pathways during active and passive immunizationStylianos Bournazos, Jeffrey V RavetchCancer Cell|September 14, 2016
Co-targeting of Adenosine Signaling Pathways for Immunotherapy: Potentiation by Fc Receptor EngagementRony Dahan, Jeffrey V RavetchTrends in Immunology|January 2, 2007
Opposing effects of Toll-like receptor stimulation induce autoimmunity or toleranceMarc Ehlers, Jeffrey V RavetchMethods in Molecular Biology (Clifton, N.J.)|March 29, 2008
Analyzing antibody-Fc-receptor interactionsFalk Nimmerjahn, Jeffrey V RavetchCancer Immunity|August 17, 2012
Translating basic mechanisms of IgG effector activity into next generation cancer therapiesFalk Nimmerjahn, Jeffrey V RavetchCell Cycle (Georgetown, Tex.)|August 25, 2012
A general requirement for FcγRIIB co-engagement of agonistic anti-TNFR antibodiesFubin Li, Jeffrey V RavetchImmunity|January 18, 2006
Fcgamma receptors: old friends and new family membersFalk Nimmerjahn, Jeffrey V RavetchPageof 20